The global anthrax vaccine market is expected to grow at a steady CAGR of 6.7%, fueled by increasing bioterrorism threats and growing awareness about the disease. As of 2022, the market was valued at US$ 599 million and is expected to surpass valuation of US$ 1,006.33 million by 2031.
The Global Age-Related Macular Degeneration Market was valued at US$ 11.31 billion in 2023 and is expected to reach a market size of US$ 19.72 billion by 2032 at a CAGR of 7.2% During the Forecast Period 2024–2032.
Global chronic pain management market was valued at US$ 93.31 billion in 2022 and is expected to attain market size of US$ 168.68 billion by 2031 at a CAGR of 6.8% during the forecast period 2023–2031.
Global real world evidence solutions market is projected to reach US$ 9.1 billion by 2032 from US$ 2.5 billion in 2023 by growing at a CAGR of 15.5% during the forecast period 2024 to 2032.
Global genomics personalized health market was valued at US$ 17.0 billion in 2023 and is projected to attain a valuation of US$ 57.9 billion by 2032 at a CAGR of 14.6% During the Forecast Period 2024–2032.
Global bioelectric medicine market was valued at US$ 24.6 billion in 2022 and is projected to hit market revenue of US$ 39.2 billion by 2031 at a CAGR of 6.41% during the forecast period 2023-2031.
Global organoids and spheroids market was valued at US$ 905.14 million in 2023 and is projected to attain a valuation of US$ 5,581.47 million by 2032 at a CAGR of 22.42% during the forecast period 2024-2032.
The United States clinical laboratory services market is expected to reach a valuation of US$ 125.6 Bn by 2030 from 93.0 billion in 2022 at a CAGR of 4.2% over the forecast period 2023-2030.